438 related articles for article (PubMed ID: 16214338)
1. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators.
Temperini C; Scozzafava A; Puccetti L; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5136-41. PubMed ID: 16214338
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme.
Temperini C; Scozzafava A; Vullo D; Supuran CT
Chemistry; 2006 Sep; 12(27):7057-66. PubMed ID: 16807956
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.
Temperini C; Scozzafava A; Vullo D; Supuran CT
J Med Chem; 2006 May; 49(10):3019-27. PubMed ID: 16686544
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV.
Temperini C; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2008 Sep; 16(18):8373-8. PubMed ID: 18774300
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine.
Briganti F; Mangani S; Orioli P; Scozzafava A; Vernaglione G; Supuran CT
Biochemistry; 1997 Aug; 36(34):10384-92. PubMed ID: 9265618
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I.
Temperini C; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Oct; 16(19):5152-6. PubMed ID: 16870440
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV.
Temperini C; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2007 Feb; 17(3):628-35. PubMed ID: 17127057
[TBL] [Abstract][Full Text] [Related]
8. Speeding up proton transfer in a fast enzyme: kinetic and crystallographic studies on the effect of hydrophobic amino acid substitutions in the active site of human carbonic anhydrase II.
Fisher SZ; Tu C; Bhatt D; Govindasamy L; Agbandje-McKenna M; McKenna R; Silverman DN
Biochemistry; 2007 Mar; 46(12):3803-13. PubMed ID: 17330962
[TBL] [Abstract][Full Text] [Related]
9. Structural and kinetic characterization of active-site histidine as a proton shuttle in catalysis by human carbonic anhydrase II.
Fisher Z; Hernandez Prada JA; Tu C; Duda D; Yoshioka C; An H; Govindasamy L; Silverman DN; McKenna R
Biochemistry; 2005 Feb; 44(4):1097-105. PubMed ID: 15667203
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole.
Supuran CT; Scozzafava A
J Enzyme Inhib; 2000; 15(5):471-86. PubMed ID: 11030087
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase activators: activation of human isozymes I, II and IX with phenylsulfonylhydrazido l-histidine derivatives.
Abdo MR; Vullo D; Saada MC; Montero JL; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2009 May; 19(9):2440-3. PubMed ID: 19345095
[TBL] [Abstract][Full Text] [Related]
14. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
15. Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism.
Fisher SZ; Maupin CM; Budayova-Spano M; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Voth GA; McKenna R
Biochemistry; 2007 Mar; 46(11):2930-7. PubMed ID: 17319692
[TBL] [Abstract][Full Text] [Related]
16. Mono- and di-halogenated histamine, histidine and carnosine derivatives are potent carbonic anhydrase I, II, VII, XII and XIV activators.
Saada MC; Vullo D; Montero JL; Scozzafava A; Supuran CT; Winum JY
Bioorg Med Chem; 2014 Sep; 22(17):4752-8. PubMed ID: 25082511
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
[TBL] [Abstract][Full Text] [Related]
18. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
Abbate F; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
